Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment he has made of the adequacy of the cost effectiveness of the XYLA-provided NHS diabetes prevention programme.

The NHS Diabetes Prevention Programme (NHS DPP) has been commissioned since 2016, and as of the end of September 2025, there have been over two million referrals into the programme and over 980,000 programme starts.

An independent evaluation of the NHS DPP published in 2024 demonstrated that the programme is cost effective and estimated a cost saving of £71.4 million based on the number of participants to March 2020.

The evaluation states that the NHS DPP is highly effective and continues to deliver positive outcomes, and that individuals who attended have a 46% lower risk of developing type 2 diabetes than those who do not attend.